课题基金 / 基金详情

Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression

Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
EGFR 家族和整合素串扰在乳腺癌进展中的作用
批准号:
7962739
负责人:
William Muller
金额:
$19.75万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-03-31

项目摘要

项目成果

William Muller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUIVIMARY (See Instructions): The progression of a primary mammary epithelial cell to the malignant phenotype is thought to involve multiple genetic events including the activation of dominant acting oncogenes and the loss of specific tumor suppressor genes. Of relevance to this proposal is the observation that activation of certain tyrosine kinases has been implicated in the malignant progression of a significant proportion of human breast cancers. Studies by many laboratories suggest that activation ofthe PI-3K signaling cascade plays a critical role in mammary tumor progression. The principle objective of this proposal is to elucidate the relative contribution of the EGFR family in activation of the PI-3K signaling cascade. To accomplish this objective, we plan to exploit two well characterized transgenic mouse models expressing either ErbB2 under the transcriptional control of the MMTV promoter (NDL) or under its own transcriptional control (ErbB2KI). In particular we plan to assess the relative contribution of ErbBS and its coupled downstream signaling molecules including PI-3K, Aktl and Akt2. Finally, we also will examine the in vivo role of Rab25 and its effector Rab coupling protein (RCP) in ErbB2 mammary tumor progression
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conference-FASEB Growth Factor Receptor Tyrosine Kinases
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
Role of EGFR Family and Integrin Crosstalk in Breast Cancer Progression
国内基金
海外基金
新融合基因TFG-FGFR1与RUNX1突变的协同致病作用与机制研究
  • 批准号:
    82000132
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王征
  • 依托单位:
基于AKT/TPR-FGFR1通路在8p11骨髓增殖综合征中的作用及机制研究
  • 批准号:
    81800126
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    李锋
  • 依托单位:
RBPMS-FGFR1新融合基因的克隆及致病机制研究
  • 批准号:
    81500103
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    晁红颖
  • 依托单位: